https://www.avient.com/sites/default/files/2024-09/Compensation Committee Charter July 2024.pdf
General Purposes The general purposes of the Committee are to: • Oversee the Company’s overall executive compensation philosophy and objectives; • Discharge the Board’s responsibilities relating to compensation of the Company’s executive officers (for purposes of this Charter, “executive officers” means the Company’s Section 16 “officers” as defined under Rule 16a-1(f) under the Securities Exchange Act of 1934, as amended); • Assist the Board in the discharge of its fiduciary responsibilities with regard to establishment of policies governing, and the implementation of, all aspects of executive officer compensation throughout the Company, including benefits and perquisites, and compensation for any other employees designated by the Committee for such purposes; • Discharge similar responsibilities with respect to the compensation of non-employee directors; • Review and discuss with management the Company’s disclosures in the Compensation Discussion and Analysis (the “CD&A”) required by rules and regulations of the Securities and Exchange Commission (the “SEC”) and recommend to the Board whether the CD&A should be included in the Company’s proxy statement or other applicable SEC filings; • Prepare a Compensation Committee Report for inclusion in the Company’s applicable filings with the SEC that complies with the rules and regulations of the SEC; and • Provide policy guidance and oversight on significant human resource policies and practices. 2 Duties and Responsibilities The Committee will: Executive Compensation and Incentives. • Oversee and maintain a competitive executive officer compensation program in order to attract and retain qualified executives and to provide incentives to executive officers that reward pay for performance in attaining the Company’s goals and objectives. • Review and approve a peer group of companies to be used for marketplace trend analysis and to assess the competitiveness of the Company’s total compensation opportunities for executive officers. • Review and approve corporate goals and objectives relevant to the Chief Executive Officer’s compensation; in conjunction with the evaluation conducted by the Board as described in the Company’s Corporate Governance Guidelines, evaluate the Chief Executive Officer’s performance in light of these goals and objectives; and determine and approve (or determine and approve, and recommend to the independent members of the Board for their determination and approval) the Chief Executive Officer’s compensation level based on this evaluation and comparable market data provided by an independent compensation consultant. • In determining the long-term incentive component of the Chief Executive Officer’s compensation, consider the Company’s performance and relative shareholder return, the value of similar incentive awards to chief executive officers at comparable companies, and the awards given to the Chief Executive Officer in the past. • Review and approve the compensation of other executive officers of the Company, including benefits and perquisites, taking into consideration the Company’s performance, comparable market data, the performance of each executive officer, and such other factors as may, in the Committee’s discretion, be appropriate. • In evaluating and making recommendations regarding, or determining and approving, executive compensation, the Committee shall consider the results of the most recent shareholder advisory vote on executive compensation (“Say on Pay Vote”) required by Section 14A of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). • With respect to incentive compensation plans and equity-based plans: • Make recommendations to the Board with respect to the approval of incentive compensation plans for executive officers and all equity-based plans. • Review and approve equity-based grants and awards, including long-term incentive plan awards, to officers, senior managers, key employees, and other employees of the Company and its subsidiaries under the Company’s equity-based plans. • Review and approve the performance criteria, target awards, payout criteria and like items for the Company’s long-term incentive compensation plans. • Review and approve (a) attainment levels for executive officers under the Company’s annual incentive plan; (b) payments to executive officers under the annual incentive plan; and (c) payments to executive officers under the Company’s long-term incentive compensation plans. • Administer the Company’s equity-based incentive compensation plans and other plans 3 adopted by the Board that contemplate administration by the Committee. • Review and approve special bonuses and/or other awards to executive officers on a case-by- case basis for outstanding performance. • Review and approve the terms of all employment agreements, management continuity agreements and change in control agreements for elected officers.
Oversee Regulatory Compliance. • Review and assess risks arising from the Company’s compensation policies and practices for its executive officers and employees, and whether any such risks are reasonably likely to have a material adverse effect on the Company. • In consultation with appropriate officers of the Company, oversee (or provide for the oversight of) regulatory compliance with respect to compensation matters, including with respect to applicable tax laws. • Review and recommend to the Board for approval the frequency with which the Company will conduct Say on Pay Votes, taking into account the results of the most recent shareholder advisory vote on the frequency of Say on Pay Votes required by Section 14A of the Exchange Act, and review and approve the proposals regarding the Say on Pay Vote and the frequency of the Say on Pay Vote to be included in the Company's proxy statement.
Review and Discuss the CD&A; Compensation Committee Report. • With the assistance of management and any outside advisers the Committee deems appropriate (a) review and discuss with management the Company’s disclosures in the CD&A, and, based on this review, make a recommendation as to whether to include it in the Company’s annual report on Form 10-K and proxy statement relating to the Company’s 4 annual meeting of shareholders, and (b) prepare a Compensation Committee Report for inclusion in the Company’s proxy statement or other applicable SEC filings.
https://www.avient.com/sites/default/files/2020-12/maxxam-fr-case-study.pdf
Not only is the material costly, it can also be challenging to process and use in thin wall cable applications.
PRODUCT FR™ 0521-48 R1 FR™ 0587-21 R3 TYPE LSFOH PP ✔ Halogenated FR PP ✔ APPLICATION Crossweb ✔ ✔ Insulation ✔ GENERAL PROPERTIES Specific gravity g/cm3 1.50 1.46 LOI % 31 34 Tensile Strength MPa 13.8 15.9 Elongation % 320 320 Dielectric constant 1MHz 3.06 2.88 Shore D - 72 75.6 T°C max/T°F Max °C/°F 232/450 232/450 FIRE PERFORMANCE UL 444 ✔ ✔ Plenum yellow card ✔ ✔
https://www.avient.com/sites/default/files/2023-09/Syncure low-voltage wire jacket and insulation case study snapshot.pdf
MAJOR W&C PRODUCER L O W - V O L T A G E W I R E J A C K E T & I N S U L A T I O N • Flame retardance • Heat resistance up to 125°C • Long term insulation resistance (LTIR) • Cold temperature resistance • Offered singular formulation capable of meeting UL-44, UL-4703, UL-1277 and CSA 22.2 listing specifications • Delivered economical solution suitable for multiple end-use commercial and residential applications • Provided on-site technical support to optimize production quality and speed Syncure™ XLPE Cross-linkable Polyethylene Formulations KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2023-07/Nymax REC - Battery Frame - Case Study Snapshot.pdf
BOS B A T T E R Y S F R A M E • Recycled materials where possible • Non-halogen flame retardant performance to V0 rating • BOS company color RAL9004 (on visible parts) • Thermal performance for some parts • High strength at low thickness for load-bearing parts • Provided multiple polymer solutions for the battery frame including recycled nylon, thermoplastic elastomers and thermally conductive formulations • Utilized recycled nylon with up to 35% glass fiber content to provide high strength for load-bearing parts at a low thickness to minimize weight • Enabled customer to launch a new innovative battery system with a modular design for use in multiple applications – maximizing the working life of the battery Nymax™ REC Recycled Nylon Formulations and Therma-Tech™ Thermally Conductive Formulations KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2023-12/Avient_ResponsibleCarePolicy_Dec_18_2023.pdf
This is achieved, in part, by ensuring compliance with applicable regulatory requirements and industry standards.
https://www.avient.com/sites/default/files/2023-12/ISO 9001 Englewood CO.pdf
PLATINUM REGISTRATION INC. 1040 South Gaylord Street, Suite 71, Denver, CO 80209 www.platinumregistration.com | info@platinumregistration.com Polystrand, Inc. 8375 Highfield Parkway, Englewood, CO, 80112 Is certified by PLATINUM REGISTRATION as a company that has developed, implemented and maintains a quality management system that conforms to the requirements of the following International Standards: ISO 9001:2015 (Requirements not applicable:8.5.5 Post-delivery activities.)
https://www.avient.com/sites/default/files/2025-01/Touchscreen Surface WithStand SX Case Study Snapshot.pdf
INJECTION MOLDER T O U C H S C R E E N S U R F A C E • Provide antimicrobial protection with strong log reduction (gram-negative / gram-positive efficacy) using globally available and cost-effective active ingredients • Incorporate a compatible recycled base resin • Utilize recyclate with no haze or discoloration (yellowing) of product, even with long-term heat aging • Maintain visual clarity while using antimicrobial raw materials with additional functional additives • Offered expertise in antimicrobial solutions, application development, and versatile product forms • Provided non-public health claims and reduced material use with recycled polycarbonate • Delivered strong efficacy >Log 2 against gram- negative and gram-positive bacteria • Supported a safe, hygienic environment while maintaining clarity and performance using a masterbatch with recycled content Cesa WithStand SX Low Haze Antimicrobial Additives KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2023-09/65567-Certificate-08SEP2023.pdf
ISO 13485:2016 The Quality Management System is applicable to: Certificate No: 65567 Effective Date: 08 September 2023 Expiration Date: 07 September 2026 Revision Date: 08 September 2023 Dominic Townsend, President This certificate may be found on the ABS QE Website (www.abs-qe.com).
https://www.avient.com/sites/default/files/2022-09/54139-Certificate-29AUG2022%5B98%5D.pdf
ISO 13485:2016 The Quality Management System is applicable to: Certificate No: 54139 Certification Date: 04 September 2019 Effective Date: 29 August 2022 Expiration Date: 01 September 2025 Revision Date: 29 August 2022 Dominic Townsend, President This certificate may be found on the ABS QE Website (www.abs-qe.com).
https://www.avient.com/sites/default/files/resources/NEU%2520ISO%25209001-2015%2520Exp%25201-22%2520%25281%2529.pdf
ISO 9001:2015 The Quality Management System is applicable to: Certificate No: 47804 Certification Date: 07 January 2013 Effective Date: 17 December 2018 Expiration Date: 06 January 2022 Issue Date: 17 December 2018 Alex Weisselberg, President This certificate may be found on the ABS QE Website (www.abs-qe.com).